Printer Friendly

ATRIX LABORATORIES BROADENS RESEARCH IN DRUG DELIVERY ARENA

 FT. COLLINS, Colo., Nov. 19 ~PRNewswire~ -- Atrix Laboratories, Inc., (NASDAQ: ATRX) announced that the company's board of directors has endorsed a strategy that will enable Atrix to broaden its research efforts for its proprietary ATRIGEL(TM) technology in the drug delivery arena. The company's expanded focus will now include research for the following applications: post operative pain, tissue repair factors, heroin addiction and medical devices such as surgical adhesions.
 Dr. G. Lee Southard, president and chief executive officer stated: "We are extremely excited about the significant opportunities for our ATRIGEL drug delivery system that a recent independent market study confirmed. Due to the unique characteristics inherent in our proprietary technology, the Atrigel drug delivery system lends itself very well to systemic and local delivery for these new applications.
 "As with the agreement by Colgate to market our Perio Product containing sanguinarine and our guided tissue regeneration product ATRISORB(TM) and our licensing agreement with Upjohn for products in the animal healthcare field, we will be seeking to form additional alliances with pharmaceutical companies for further development of our ATRIGEL system."
 Atrix Laboratories is a drug delivery company with a unique, proprietary drug delivery technology that is biodegradable and can be utilized for a broad range of human and animal applications, including the treatment of periodontal disease.
 -0- 11~19~92
 ~CONTACT: Dr. G. Lee Southard, president and chief executive officer of Atrix Laboratories, Inc., 303-482-5868, or Susan Sherman of Cameron Associates, 212-644-9560, for Atrix Laboratories, Inc.~
 (ATRX)


CO: Atrix Laboratories, Inc. ST: Colorado IN: MTC SU:

AH-OS -- NY090 -- 3026 11~19~92 15:09 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 19, 1992
Words:265
Previous Article:AT&T EMPLOYEE GROUP HONORS VICE PRESIDENT RICHARD A. ROMANO FOR PROMOTING DIVERSITY
Next Article:WILLCOX & GIBBS NAMES ROBERT MERSON VICE PRESIDENT
Topics:


Related Articles
ATRIX LABORATORIES NAMES JOHN E. URHEIM AS VICE CHAIRMAN AND CHIEF EXECUTIVE OFFICER
ATRIX LABORATORIES AND SYNTEX SIGN AGREEMENT
ATRIX LABORATORIES ANNOUNCES YEAR END RESULTS
ATRIX LABORATORIES REPORTS INTERIM RESULTS
ATRIX LABORATORIES ANNOUNCES SECOND QUARTER RESULTS
ATRIX LABORATORIES ANNOUNCES THIRD QUARTER RESULTS
ATRIX SIGNS WORLDWIDE LICENSE AGREEMENT WITH UPJOHN
ATRIX LABORATORIES ANNOUNCES CLOSING OF COMMON STOCK OFFERING
ATRIX LABORATORIES REPORTS FIRST QUARTER RESULTS
Atrix Laboratories strengthens patent position.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters